Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamide.

MLA

Patterson, Michael T., et al. “Efflux Capacity and Aldehyde Dehydrogenase Both Contribute to CD8+ T-Cell Resistance to Posttransplant Cyclophosphamide.” Blood Advances, vol. 6, no. 17, Sept. 2022, pp. 4994–5008. EBSCOhost, https://doi.org/10.1182/bloodadvances.2022006961.

APA

Patterson, M. T., Nunes, N. S., Wachsmuth, L. P., Panjabi, A., Fletcher, R. E., Khan, S. M., Dimitrova, D., Kanakry, J. A., Luznik, L., & Kanakry, C. G. (2022). Efflux capacity and aldehyde dehydrogenase both contribute to CD8+ T-cell resistance to posttransplant cyclophosphamide. Blood Advances, 6(17), 4994–5008. https://doi.org/10.1182/bloodadvances.2022006961

Chicago

Patterson, Michael T, Natalia S Nunes, Lucas P Wachsmuth, Amrit Panjabi, Rochelle E Fletcher, Shanzay M Khan, Dimana Dimitrova, Jennifer A Kanakry, Leo Luznik, and Christopher G Kanakry. 2022. “Efflux Capacity and Aldehyde Dehydrogenase Both Contribute to CD8+ T-Cell Resistance to Posttransplant Cyclophosphamide.” Blood Advances 6 (17): 4994–5008. doi:10.1182/bloodadvances.2022006961.